Evaluation of virulence in various Candida species: In vitro and in vivo study;Çeşitli Candida türlerinde virülansın deǧerlendirilmesi: İn vitro ve i̇n vivo çalışma

Turkiye Klinikleri Journal of Medical Sciences

Volumn 30, Issue 5, 2010, Pages 1493-1502

  Gürcan, Şaban ^a   Alver, Oktay ^a   Ercan, Ilker ^a   Ener, Beyza ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Cell adhesion; Fungemia; Lysophospholipase; Virulence factors

Indexed keywords

PHOSPHATE BUFFERED SALINE; PHOSPHOLIPASE; PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CELL ADHESION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; EPITHELIUM CELL; FUNGAL METABOLISM; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MOUSE; NEUTROPENIA; NONHUMAN;

EID: 78249265327     PISSN: 13000292     EISSN: None     Source Type: Journal    
DOI: 10.5336/medsci.2009-16724     Document Type: Article

References (34)

1. Beck-Sagué C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993;167(5): 1247-51.
2. Douglas LJ. Adhesion of Candida species to epithelial surfaces. Crit Rev Microbiol 1987;15 (1):27-43.
3. Douglas JL. Adhesion to surface. In: Rose AH, Harrison JS, eds. The Yeast. 2nd ed. London: Academic Pres; 1987. p. 239-45.
4. Barrett-Bee K, Hayes Y, Wilson RG, Ryley JF. A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol 1985;131(5): 1217-21.
5. Borg M, Rüchel R. Expression of extracellular acid proteinase by proteolytic Candida species during experimental infection of oral mucosa. Infect Immun 1998;56(3): 626-31.
6. Ross IK, Bernardis F, Emerson GW, Cassone A, Sullivan P. The secreted aspartate proteinase of Candida albicans: physiology of a proteinase deficient mutant. J Gen Microbiol 1991;136(4):163-8.
7. Farley PC, Shepherd MG, Sullivan PA. The purification and properties of yeast proteinase B from Candida albicans. Biochem J 1986; 236(1):177-84.
8. Odds FC. Candida albicans proteinase as a virulence factor in the pathogenesis of Candida infections. Zentralbl Bakteriol Mikrobiol Hyg A 1985;260(4):539-42.
9. Remold H, Fasold H, Staib F. Purification and characterization of a proteolytic enzyme from Candida albicans. Biochim Biophys Acta 1968;167(2):399-406.
10. Macdonald F. Secretion of inducibl e proteinase by pathogenic Candida species. Sabouraudia 1984;22(1):79-82.
11. Rüchel R, Böning B, Borg M. Characterization of a secretory proteinase of Candida parapsilosis and evidence for the absence of the enzyme during infection in vitro. Infect Immun 1986;53(2):411-9.
12. Tsushima H, Mine H, Kawahami Y, Hyodok F, Ueki A. Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A. Microbiology 1994;140(Pt 1):167-71.
13. Loui A, Dixon DM, el-Magrabi EA, Burnet JW, Baltch AL, Smith RP. Relationship between Candida albicans epidermolytic proteinase activity and virulance in mice. J Med Vet Mycol 1994;32(1):59-64.
14. McGinnis MR, Tilton RC. Yeast. In: Howard BJ, Keiser JK, Weissfeld AS, Smith T, Tilton RC, eds. Clinical and Pathogenic Microbiology. 2nd ed. St Louis Baltimore Boston: Mosby; 1994. p. 615-25.
15. Ener B, Douglas LJ. Correlation between cell-surface hydrophobicity of Candida albicans and adhesion to buccal epithelial cells. FEMS Microbiol Lett 1992;78(1): 37-42.
16. Samaranayake LP, Raeside JM, MacFarlene TW. Factors affecting the phospholipase activity of Candida species in vitro. J Med Vet Mycol 1984;22(3):201-7.
17. Ener B, Babacan F, Johansson CB. In vitro detection of phospholipase activity in Candida species. Med Bull İstanbul 1991; 24(1):55-60.
18. Özgüneş I, Usluer G, Gürer F, Çolak H. Efficacy of prophylactic and early fluconazole treatment on systemic candidiasis in experimentally neutropenic rabbit. Chemotherapy 1993;39(3):189-96.
19. Aldenderfer MS, Blashfield RK. A review of clustering methods. Cluster Analysis. 1st ed. London: Sage Publication Inc; 1984. p. 33-61.
20. Ercan I, Tanritanir A, Hacimustafaoǧiu M, Ediz B. [Evaluation of clinical data of the patients internalized with diagnosis as acute diarrhea via cluster analysis]. Ege Journal of Medicine 1998;37(1-2):25-30.
21. Sugar MA. Problems in diagnosis of invasive candidiasis in the immunocompromised patients. In: Rex JH, Meunier F, eds. Serious Candida Infections: Risk Factors, Treatment and Prevention. 2nd ed. New York: Medical Information Press, Pfizer, Inc; 1995. p. 27-33.
22. Ghannoum MA. Extracellular phospholipases as universal virulence factor in pathogenic fungi. Nippon Ishinkin Gakkai Zasshi 1998;39(2):55-9.
23. Dolan JW, Bell AC, Hube B, Schaller M, Warner TF, Balish E. Candida albicans PLD I activity is required for full virulence. Med Mycol 2004;42(5):439-47.
24. Dagdeviren M, Cerikcioglu N, Karavus M. Acid proteinase, phospholipase and adherence properties of Candida parapsilosis stra ins isolated from clinical specimens of hospitalised patients. Mycoses 2005;48(5):321-6.
25. Yücesoy M, Karaman M, Yuluǧ N. Saǧlikli{dotless} ve [Candida albicans strains isolated from both healthy individuals and Candida infected patients]. Turkish J Infect 2000;14(3): 405-8.
26. GüIenç S, Karadenizli A, Kolayli{dotless} F, Bingöl R. [Investigation of slime factor and proteinase activity in yeast species isolated from various clinical specimens]. J Turkish Microbiol Soc 2002;32(3-4):235-8.
27. Gokce G, Cerikciogl u N, Yagci A. Acid proteinase, phospholipase, and biofilm pr duction of Candida species isolated from blood cultures. Mycopathologia 2007;164(6): 265-9.
28. Odds FC. Candida species and virulence. ASM News 1994;60(6):313-8.
29. Chaffin WL, Lopez-Ribot JL, Casanova M, Gozalbo D, Martinez JM. Cell wall and secreted proteins of Candida albicans: identification, function and expression. Microbiol Mol Biol Rev 1998;62(1):130-80.
30. Kirdar S, Kaynak S, Duran A, Doǧan Y, Bahar IH. [The effect of silicone oil on in vitro growth and some virulence factors of Candida albicans]. Turkiye Klinikleri J Med Sci 2009;29(5):1247-52.
31. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-ac- quired candidemia: a matched case-control study. Arch Inter Med 1989;149(10): 2349-53.
32. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors and predictors of mortality. Clin Infect Dis 1992;15(3):414-21.
33. Schwartz RS, Mackintosh FR, Schrier SL, Greenberg PL. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer 1984;53(3): 411-9.
34. Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL. Risk factors for nosocomial candidemia: a case control study in adults without leukemia. Am J Med 1989;87(6):614-9.